Hygosap Pharma Private Limited
About Hygosap Pharma Private Limited
Data last updated:
Hygosap Pharma Private Limited is a private limited company based in Delhi, India, a subsidiary of Akums Drugs And Pharmaceuticals Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 22 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2021PTC376044. Its GSTIN is 07AAJCB5832H1ZM (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹10.1 Lakh and a paid-up capital of ₹10.1 Lakh. It was formerly known as Burroughs Welcome Pharmacia Private Limited. It is led by directors including Shivangi Jain and Arushi Jain.
Its last annual general meeting (AGM) was held on 31 May 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at Unit No. 201 2nd Floor Lsc Mohan Place Blk – C Saraswati Vihar Pitampura, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹3.45 Lakh, a growth of 74% compared to the previous year. For the same year it recorded a net profit of ₹59,000 (net margin 17.1%) and EBITDA of ₹85,000 (EBITDA margin 24.6%). Revenue has declined at a compounded annual rate (CAGR) of 85% over three years.
Court records list 27 cases involving the company, including 27 filed by the company; 20 cases are pending.
Company details
Contact details
Hygosap Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressUnit No. 201 2nd Floor Lsc Mohan Place Blk – C Saraswati Vihar Pitampura, Delhi, India – 110034
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Hygosap Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hygosap Pharma Private Limited
FY 2026 filings availableHygosap Pharma Private Limited reported revenue of ₹3.45 Lakh (up 74% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue rose 74% in the latest year, though over three years it has declined at a compounded annual rate (CAGR) of 85%. EBITDA fell 51% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹3.45 Lakh | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹85,000 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹59,000 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 24.6% | ||||
| Net Profit Margin | 17.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Hygosap Pharma Private Limited, buy the company report.
Board of directors of Hygosap Pharma Private Limited
Hygosap Pharma has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Shivangi Jain | Director | 24 Mar 2022 | 4 Years 7 Months | Current |
| Arushi Jain | Director | 22 Jan 2021 | 5 Years 9 Months | Current |
| Umang Jain | Director | 27 Feb 2021 | 5 Years 8 Months | Current |
Auditor
Hygosap Pharma Private Limited is audited by T A M S & CO. LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T A M S & CO. LLP | FY 2026 | 038010N/N500416 |
Shareholding
The shareholding of Hygosap Pharma Private Limited is on record for 4 financial years, the latest being FY 2026, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2026 | FY 2025 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Hygosap Pharma Private Limited, buy the company report.
Legal cases
Hygosap Pharma Private Limited has 27 court cases on record: 27 filed by Hygosap Pharma. 20 cases are pending and 7 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 27 | 0 | 20 |
Cases on record (5 of 27)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against Activentis Biotech Pvt Ltd | Pending |
| District court, North West, Delhi | Cheque dishonour complaint | Filed by the company against M/S Balaji Chemist and Druggist Private Limited and Ors and 2 others | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
To see the full case history of Hygosap Pharma Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hygosap Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Hygosap Pharma Private Limited has 1 active EPFO establishment as of Mar 26, 2024.
GST
Hygosap Pharma has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAJCB5832H1ZM | Delhi | Active | 27 Aug 2021 |
| 06AAJCB5832H1ZO | Haryana | Active | 31 Dec 2021 |
To see the full GST registrations and return filing status of Hygosap Pharma Private Limited, buy the company report.
Recent activity
Hygosap Pharma Private Limited has 7 board changes on record since 2021: 3 appointments and 4 cessations. The latest: Pranav Trikha ceased to be Additional Director on 20 May 2023.
Frequently asked questions
Hygosap Pharma is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 22 January 2021 (5+ years old) and is registered under CIN U24290DL2021PTC376044.
Hygosap Pharma has 3 current directors:
- Shivangi Jain - Director
- Arushi Jain - Director
- Umang Jain - Director
The latest financial statements of Hygosap Pharma on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 31 May 2026. Year-wise statements from FY 2021 are in the company report.
The GSTIN of Hygosap Pharma is 07AAJCB5832H1ZM, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 06AAJCB5832H1ZO (Haryana).
The CIN (Corporate Identification Number) of Hygosap Pharma is U24290DL2021PTC376044. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Hygosap Pharma has 27 court cases on record: 27 filed by the company. 20 are pending.
Hygosap Pharma was incorporated on 22 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
Pranav Trikha ceased to be Additional Director on 20 May 2023. Shivangi Jain ceased to be Additional Director on 03 Jul 2022. Umang Jain ceased to be Additional Director on 03 Jul 2022. Hygosap Pharma has 7 board changes on record in total.
The registered office of Hygosap Pharma is at Unit No. 201 2nd Floor Lsc Mohan Place Blk – C Saraswati Vihar Pitampura, Delhi, India – 110034.
Hygosap Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
